Expanding its presence in the diagnostics market, life sciences company Agilent Technologies Inc. will pay $2.2bn in cash to buy Dako AS (cancer testing) from private equity firm EQT Partners. (May)
A large part of Dako’s business is from the sale of immunohistochemistry (IHC) tests to pathology labs. The company also markets antibodies, molecular pathology products (including FISH kits and probes),...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?